¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"Estrogen excess"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
¿µ¹® estrogen ÇÑ±Û ¿¡½ºÆ®·Î°Õ
¼³¸í   
  ³­¼Ò¾È¿¡ Àִ ³­Æ÷¿¡¼­ ºÐºñµÇ´Â ³­Æ÷È£¸£¸óÀÇ ÃÑĪ. ¿©Æ÷È£¸£¸ó, ¹ßÁ¤ È£¸£¸óÀ̶ó°íµµ ÇÑ´Ù. ¿¡½ºÆ®·Î°ÕÀ̶õ »ý¹°ÇÐÀûÀΠ¸íĪÀ̸砵¿¹°ÀÇ ¹ßÁ¤ÀÛ¿ë ¿Ü¿¡ ¿©·¯ °¡Áö ÀÛ¿ëÀ» Áö´Ñ ¹°ÁúÀÇ ÃÑĪÀÌ´Ù. »ç¶÷¿¡´Â 20Á¾ ÀÌ»óÀÇ ¿¡½ºÆ®·Î°ÕÀÇ Á¾·ù°¡ ÀÖÁö¸¸, ±×Áß¿¡¼­µµ estrone, estradiol, estriolÀÇ 3°¡Áö°¡ °¡Àå Áß¿äÇÏ´Ù. ¿¡½ºÆ®·Î°ÕÀº ºñÀӽŽÿ¡´Â ¿©Æ÷È£¸£¸óÀÇ Á¶Àý¿¡ ÀÇÇØ¼­, ÁַΠ³­¼Ò¿¡¼­ »ý¼ºµÇ¸ç, ÀӽŽÿ¡´Â ÁַΠŹݿ¡¼­ ¸¸µé¾îÁöÁö¸¸, estriolÀº Å¾ÆÀÇ ºÎ½Å°ú Å¹ÝÀÇ ÇÕµ¿ÀÛ¿ë¿¡ ÀÇÇØ¼­ ¸¸µç´Ù. »ç¶÷¿¡°Ô À־ ¿¡½ºÆ®·Î°ÕÀÇ ÁֵȠÀÛ¿ëÀº ´ÙÀ½°ú °°Àº °ÍÀÌ ÀÖ´Ù.
  
  1. Á¦ 2Â÷ ¼ºÂ¡ÀÇ ¹ßÇö. 2. ³»¼º±â, Áú, ¿Ü¼º±âÀÇ ¹ßÀ°ÃËÁø 3. Àڱ󻸷 ¹× ¼º±â »óÇÇÀÇ Áõ½Ä 4. ¹è¶õ±â¿¡ ÀÚ±ÃÀÇ ÀÔ±¸ÀΠ¸ñ¿¡ Á¡¾×À» Áõ·®½ÃÄÑ Á¤ÀÚÀÇ Åë°ú¼ºÀ» ÁÁ°Ô ÇÑ´Ù. 5. ÀӽŽÿ¡ ¼º±â¿Í À¯¹æ µî¿¡ Àӽżº º¯È­¸¦ ÀÏÀ¸Å²´Ù. 6. ¼º±âÀÇ ±ÙÀ°À» Áõ½Ä½ÃÄÑ ¿îµ¿¼ºÀ» Áõ°¡½ÃŲ´Ù. 7. ´Ü¹éÁú ÁöÁú, ¹«±âÁú µîÀÇ ¹°Áú´ë»ç³ª ¿©·¯ °¡Áö È¿¼ÒÀÇ ÀÛ¿ë¿¡ ¿µÇâÀ» ÁØ´Ù. 8. ¹è¶õ°ú »ý¸® ÁÖ±âÀÇ À¯Áö¿¡ °ü¿©ÇÑ´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • conjugated estrogen
    °áÇÕ¿¡½ºÆ®·Î°Õ
  • estrogen
    ¿¡½ºÆ®·Î°Õ
  • estrogen challenge test
    ¿¡½ºÆ®·Î°ÕºÎÇϰ˻ç
  • estrogen cream
    ¿¡½ºÆ®·Î°ÕÅ©¸²
  • estrogen receptor
    ¿¡½ºÆ®·Î°Õ¼ö¿ëü
  • estrogen replacement therapy
    ¿¡½ºÆ®·Î°Õ´ëÄ¡¿ä¹ý
  • antibody excess
    Ç×ü°úÀ×
  • antibody excess zone
    Ç×ü°úÀ×±¸¿ª
  • antigen excess
    Ç׿ø°úÀ×
  • antigen excess zone
    Ç׿ø°úÀ×±¸¿ª
  • accommodative excess
    Á¶Àý°ú´Ù
  • base excess
    ¿°±â°úÀ×
  • convergence excess
    ´«¸ðÀ½°ú´Ù
  • divergence excess
    ´«¹ú¸²°ú´Ù, °³»ê°ú´Ù
  • divergence excess exotropia
    ´«¹ú¸²°ú´Ù¿Ü»ç½Ã, °³»ê°ú´Ù¿Ü»ç½Ã
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 6 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • excess
    °ú´Ù, °úÀ×
  • antigen excess
    Ç׿ø°úÀ×
  • estrogen cream
    ¿¡½ºÆ®·Î°ÕÅ©¸²
  • estrogen
    1.¿©¼ºÈ£¸£¸ó, 2.¿¡½ºÆ®·Î°Õ
  • estrogen challenge test
    ¿©¼ºÈ£¸£¸óºÎÇϰ˻ç
  • estrogen replacement therapy
    ¿©¼ºÈ£¸£¸ó´ëü¿ä¹ý
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • conjugated estrogen
    °áÇÕ¿¡½ºÆ®·Î°Õ
  • estrogen
    ¿©¼ºÈ£¸£¸ó, ¿¡½ºÆ®·Î°Õ
  • estrogen window hypothesis
    ¿¡½ºÆ®·Î°Õâ°¡¼³
  • accommodative excess
    Á¶Àý°ú´Ù
  • antibody excess
    Ç×ü°úÀ×
  • antibody excess zone
    Ç×ü°úÀ×±¸¿ª
  • antigen excess
    Ç׿ø°úÀ×
  • antigen excess zone
    Ç׿ø°úÀ×±¸¿ª
  • base excess
    ¿°±â°úÀ×
  • convergence excess
    ´«¸ðÀ½°ú´Ù
  • excess chlorine
    °úÀ׿°¼Ò
  • divergence excess
    ´«¹ú¸²°ú´Ù
  • divergence excess exotropia
    ´«¹ú¸²°ú´Ù¿Ü»ç½Ã
  • excess
    °ú´Ù, °úÀ×
  • excess mortality
    Ãʰú»ç¸Á·ü
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 9 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • accommodative excess
    Á¶Àý°ú´Ù
  • antibody excess
    Ç×ü°úÀ×(ù÷ô÷Φí¥).
  • antibody excess zone
    Ç×ü°úÀ×´ë(ù÷ô÷Φí¥Óá).
  • antibody excess zone
    Ç×ü°úÀ×´ë(ù÷ô÷Φí¥Óá).
  • antibody excess zone
    Ç×ü°úÀ×´ë(ù÷ô÷Φí¥Óá).
  • antigen excess
    Ç׿ø°ú´Ù(ù÷ê«Î¦Òý).
  • antigen excess zone
    Ç׿ø°úÀ×´ë.
  • antigen excess zone
    Ç׿ø°úÀ×´ë.
  • antigen excess zone
    Ç׿ø°úÀ×´ë.
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • conjugated estrogen
    °áÇÕ¿¡½ºÆ®·Î°Õ.
  • estrogen
    ¿¡½ºÆ®·Î°Õ, ³­Æ÷È£¸£¸ó
  • estrogen
    ¿¡½ºÆ®·Î°Õ, ³­Æ÷È£¸£¸ó
  • estrogen
    ¸®¿¡½ºÆ®·Î°Õ, ³­Æ÷(Õ°øà)È£¸£¸ó.
  • estrogen
    ¿¡½ºÆ®·Î°Õ
  • estrogen
    ¿¡½ºÆ®·Î°Õ.
  • estrogen
    ¸®¿¡½ºÆ®·Î°Õ, ³­Æ÷È£¸£¸ó.
  • estrogen phase
    ¿¡½ºÆ®·Î°Õ±â(Ñ¢).
  • estrogen phase
    ¿¡½ºÆ®·Î°Õ±â.
  • estrogen receptor protein
    ¸®¿¡½ºÆ®·Î°Õ ¼ö¿ë(áôé») ´Ü¹éÁú(Ó±ÛÜòõ).
  • estrogen receptor protein
    ¿¡½ºÆ®·Î°Õ¼ö¿ëü´Ü¹éÁú.
  • estrogen window hypothesis
    ¿¡½ºÆ®·ÎÁ¨ ±¸°£°¡¼³
  • accommodative excess
    Á¶Àý°ú´Ù
  • antibody excess
    Ç×ü°úÀ×(ù÷ô÷Φí¥).
  • antibody excess zone
    Ç×ü°úÀ×´ë(ù÷ô÷Φí¥Óá).
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 6 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • estrogen
    ¿¡½ºÆ®·ÎÀü
  • antibody-excess zone
    Ç×ü°úÀ×±¸¿ª(ù÷ô÷Φí¥Ï¡æ´)
  • antigen-excess zone
    Ç׿ø°úÀ× ±¸¿ª(ù÷ê«Î¦í¥Ï¡æ´)
  • atomic percent excess
    °ú´Ù ¿øÀÚ¹éºÐÀ²(ΦÒýê«í­ÛÝÝÂëÒ)
  • primary alkali excess
    ¿ø¹ß¼º(ê«Û¡àõ) ¾ËÄ®¸®°úÀ×(Φí¥)
  • primary carbon dioxide excess
    ¿ø¹ß¼º ÀÌ»êȭź¼Ò(ê´Û¡àõ ì£ß«ûù÷©áÈ) °úÀ×(Φí¥)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 2 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • estrogen
    ¿¡½ºÆ®·Î°Õ, ³­Æ÷È£¸£¸ó
  • excess
    °úÀ×, À׿©
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
HCG, hCG Human Chorionic Gonadotropin; »ç¶÷À¶¸ð¼º¼º¼±ÀÚ±ØÈ£¸£¸ó
  1. Placental Glycoprotein Hormone
&nbs...
BE   1) Bacterial Endocarditis
  2) Base Excess
  3) Below the Elbo...
ECG Electro-Cardio-Graphy(-Gram); ½ÉÀüµµ
   = EKG
  1. Conducting System Structu...
RAEB Refractory Anemia with Excess of Blasts
RAEB-T Refractory Anemia with Excess Blasts in Transformation
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
AME Apparent Mineralocorticoid Excess
BE Base Excess
EWL Excess Weight Loss
EPOC Excess post-exercise oxygen consumption
RAEB RA with an excess of blasts
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
  • E28.0
    Estrogen excess
    ¿¡½ºÆ®·Î°Õ °ú´Ù
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 13 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • conjugated estrogen
    °áÇÕ ¿¡½ºÆ®·Î°Õ
  • estrogen
    ¿©¼º È£¸£¸ó
  • estrogen receptor protein
    ¿¡½ºÆ®·Î°Õ ¼ö¿ëü ´Ü¹éÁú
  • antibody excess zone
    Ç×ü °úÀ׿ª
  • antigen excess
    Ç׿ø °úÀ×
    ħ°­ ¹ÝÀÀ µî ÃÖÀûºñ¿¡¼­ ¹ÝÀÀÀÌ Àß °üÂûµÇ´Â °æ¿ì Ç׿øÀÇ ¾çÀÌ Áö³ªÄ¡°Ô ¸¹À¸¸é ¹Ý´ë·Î ¹ÝÀÀÀÌ ¾àÇØÁö°í °üÂûÀÌ °¡´ÉÇÑ ¹ÝÀÀÀÌ »ý±æ ¶§±îÁöÀÇ ½Ã°£ÀÌ ±æ¾îÁø´Ù. ÀÌ¿Í °°ÀÌ Ç׿øÀÌ °úÀ×µÇ¾î ¹ÝÀÀÀÌ °üÂûµÇÁö ¾Ê°Ô µÇ´Â °æ¿ì Ç׿ø °úÀ׿¡ ÀÇÇÑ ¹ÝÀÀÀÇ ¾ïÁ¦Çϰí ÇÑ´Ù. Ç׿ø Ç×ü º¹ÇÕü´Â Ç׿ø °úÀ×ÀÎ °æ¿ì¿¡´Â °¡¿ë¼ºÀÌ µÈ´Ù.
  • creatinaemia : excess of creatine in the blood.

    creatine kinase

    Å©·¹¾ÆÆ¾ Ű³ª¾ÆÁ¦
  • excess
    °úÀ×, À׿©
  • excess chlorine
    °úÀ× ¿°¼Ò
  • excess factor
    °úÀ× ÀÎÀÚ
  • excess lactate
    °úÀ× À¯»ê, °úÀ× À¯»ê¿°
  • excess sludge
    °úÀ× ½½·¯Áö
  • excess water
    À׿© ¼öºÐ
  • zone of antigen excess
    Ç׿ø °úÀ×´ë
    ºñ±³Àû °í³óµµÀÇ Ç׿ø´ë·Î¼­ ħ°­¹ÝÀÀ¿¡¼­ °¡¿ë¼º º¹ÇÕü°¡ Çü¼ºµÇ¸ç ¹ÝÀÀÀÌ ¾ïÁ¦µÈ´Ù.
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
estrogen <endocrinology, hormone> A generic term for oestrus producing steroid compounds, the female sex hormones.
In humans, oestrogen is formed in the ovary, possibly the adrenal cortex, the testis and the foetoplacental unit, it has various functions in both sexes. It is responsible for the development of the female secondary sex characteristics and during the menstrual cycle it acts on the female genitalia to produce an environment suitable for the fertilization, implantation and nutrition of the early embryo.
Oestrogen is used in oral contraceptives and as a palliative in cancer of the breast after menopause and cancer of the prostate, other uses include the relief of the discomforts of menopause, inhibition of lactation and treatment of osteoporosis, threatened abortion and various functional ovarian disorders.
(18 Nov 1997)
estrogen 2-hydroxylase <enzyme> Same enzyme for hydroxylation in 2 or 4 position
Registry number: EC 1.14.99.-
Synonym: estrogen 4-hydroxylase, ethinylestradiol 2-hydroxylase
(26 Jun 1999)
anaemia, refractory, with excess of blasts Chronic refractory anaemia with granulocytopenia, and/or thrombocytopenia. Myeloblasts and progranulocytes constitute 5 to 40 percent of the nucleated marrow cells.
(12 Dec 1998)
antibody excess In a precipitation test, the presence of antibody in an amount greater than that required to combine with all of the antigen present.
(05 Mar 2000)
antigen excess In a precipitation test, the presence of uncombined antigen above that required to combine with all of the antibody; precipitation may be inhibited because the presence of excess antigen gives rise to soluble antigen-antibody complexes, in vivo the resultant antigen-antibody interaction in such an antigen excess may give rise to immune complexes, which have a potential to induce cellular damage; such injury underlies the pathologic changes seen in certain immune complex diseases.
(05 Mar 2000)
base excess A measure of metabolic alkalosis, usually predicted from the Siggaard-Andersen nomogram; the amount of strong acid that would have to be added per unit volume of whole blood to titrate it to pH 7.4 while at 37°C and at a carbon dioxide pressure of 40 mm Hg.
(05 Mar 2000)
calcium excess Overly high intake of calcium (hypercalcaemia) may cause muscle weakness and constipation, affect the conduction of electrical impulses in the heart (heart block) lead to calcium stones in the urinary tract, impair kidney function (through nephrocalcinosis), and interfere with the absorption of iron predisposing to iron deficiency. According to the National Academy of Sciences, adequate intake of calcium is 1 gram daily for both men and women. The upper limit for calcium intake is 2.5 grams daily.
(12 Dec 1998)
magnesium excess Persons with impaired kidney function should be especially careful about their magnesium intake because they can accumulate magnesium, a dangerous situation. According to the national academy of sciences, the recommended dietary allowances of magnesium are 420 milligrams per day for men and 320 milligrams per day for women. The upper limit of magnesium as supplements is 350 milligrams daily, in addition to the magnesium from food and water.
(12 Dec 1998)
refractory anaemia with excess blasts <haematology> A form of myelodysplasia characterised by the build up of immature white blood cells (blasts) in the bone marrow.
If the immature cells are particularly numerous it may indicate a chance of transformation to acute leukaemia and the condition is called refractory anaemia with excess blasts in transformation (RAEBt).
Acronym: RAEB
(13 Nov 1997)
convergence excess That condition in which an oesophoria or esotropia is greater for near vision than for far vision.
(05 Mar 2000)
selenium excess Too much of the mineral selenium may cause reversible changes in the hair (balding) and nails, garlic odour to the breath, intestinal distress, weakness and slower mentation (slowed mental functionning). According to the national academy of sciences, the recommended dietary allowances of selenium are 70 milligrams per day for men and 55 milligrams per day for women.
(12 Dec 1998)
negative base excess A measure of metabolic acidosis, usually predicted from the Siggaard-Andersen nomogram; the amount of strong alkali that would have to be added per unit volume of whole blood to titrate it to pH 7.4 while at 37°C and at a carbon dioxide pressure of 40 mm Hg.
(05 Mar 2000)
divergence excess exotropia Exotropia in which the strabismus is notably greater for far vision than for near vision.
(05 Mar 2000)
iodine excess Just as too little iodine can cause thyroid disease, so may prolonged intake of too much iodine also lead to the development of goiter (swelling of the thyroid gland) and hypothyroidism (abnormally low thyroid activity). Certain foods and medications contain large amounts of iodine. Examples include seaweed; iodine-rich expectorants (such as sski and lugol's solution) used in the treatment of cough, asthma, chronic pulmonary disease; and amiodarone (cardorone), an iodine-rich medication used in the control of abnormal heart rhythms (cardiac arrhythmias).
(12 Dec 1998)
iron excess Iron overload can damage the heart, liver, gonads and other organs. Iron overload is a particular risk in people who may have certain genetic conditions (haemochromatosis) sometimes without knowing it and also in people receiving recurrent blood transfusions. According to the national academy of sciences, the recommended dietary allowances of iron are 15 milligrams per day for women and 10 milligrams per day for men.
(12 Dec 1998)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 10 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • estrogen
    ¹ßÁ¤È£¸£¸ó
  • excess
    °ú´Ù(ÀÇ); ÆøÀ½(½Ä)
  • excess
    °úµµ;°ú´Ù;°úÀ×;Ãʰú;Ãʰú·®;ºÎÀýÁ¦;Áö³ªÄ§;³­Æø;ÆøÀ½Æø½Ä(excess of imports over exports ¼öÀÔ Ãʰú) a
  • excess baggage
    Á¦ÇÑ Ãʰú ¼öÇϹ°
  • excess charge
    ÁÖÂ÷ ½Ã°£ Ãʰú ¿ä±Ý
  • excess fare
    öµµÀÇ °Å¸® Ãʰú ¿ä±Ý;Ãʰú ¿ä±Ý
  • excess luggage
    =EXCESS BAGGAGE
  • excess postage
    ¿ìÇ¥ ºÎÁ· ¿ä±Ý
  • excess reserves
    (ÀºÇà)Ãʰú Áغñ±Ý
  • excess supply
    (°æ)°ø±Þ Ãʰú(°úÀ×)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á